Cerebellum (2010) 9:537–547 36. Zindy F, Knoepfler PS, Xie S, Sherr CJ, Eisenman RN, Roussel MF. N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development. Proc Natl Acad Sci USA. 2006;103:11579–83. 37. Kenney AM, Cole MD, Rowitch DH. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development. 2003;130:15– 28. 38. Zhao X, Da D, Lim WK, Brahmachary M, Carro MS, Ludwig T, et al. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev Cell. 2009;17:210– 21. 39. Zhao X, Heng JI, Guardavaccaro D, Jiang R, Pagano M, Guillemot F, et al. The HECT-domain ubiquitin ligase Huwe1 547 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nat Cell Biol. 2008;10:643–53. 40. van Bokhoven H, Celli J, van Reeuwijk J, Rinne T, Glaudemans B, van Beusekom E, et al. MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome. Nat Genet. 2005;37:465–7. 41. Teszas A, Meijer R, Scheffer H, Gyuris P, Kosztolanyi G, van Bokhoven H, et al. Expanding the clinical spectrum of MYCN- related Feingold syndrome. Am J Med Genet A. 2006;140:2254–6. 42. Marcelis CL, Hol FA, Graham GE, Rieu PN, Kellermayer R, Meijer RP, et al. Genotype-phenotype correlations in MYCN- related Feingold syndrome. Hum Mutat. 2008;29:1125–32. 43. Wey A, Knoepfler PS. c-myc and N-myc promote active stem cell metabolism and cycling as architects of the developing brain. Onco Target. 2010;1:1–10.